Laryngeal inflammatory myofibroblastic tumors: Different clinical appearance and histomorphologic presentation of one entity

Head and Neck

Volumn 32, Issue 11, 2010, Pages 1573-1578

  Völker, Hans Ullrich ^a   Scheich, Matthias ^a   Zettl, Andreas ^a   Hagen, Rudolf ^a   Müller Hermelink, Hans Konrad ^a   Gattenlöhner, Stefan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

comparative genomic hybridization; IgG4; inflammatory myofibroblastic tumor; larynx; Rb1

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; CORTICOSTEROID; CYTOKERATIN AE1; CYTOKERATIN AE3; IMMUNOGLOBULIN G4; KI 67 ANTIGEN; PARAFFIN; PROTEIN P53; PROTEIN RB1; RETINOBLASTOMA PROTEIN; SMOOTH MUSCLE ACTIN; UNCLASSIFIED DRUG; VIMENTIN; VIRUS RNA;

ADULT; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CELL INFILTRATION; CELL PROLIFERATION; CHROMOSOME 13Q; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; DYSPHONIA; EMBEDDING; EPSTEIN BARR VIRUS; FEMALE; GENE LOSS; GENE OVEREXPRESSION; HEMILARYNGECTOMY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARYNGEAL INFLAMMATORY MYOFIBROBLASTIC TUMOR; LARYNGECTOMY; LARYNGOSCOPY; LARYNX TUMOR; LASER MICRODISSECTION; MALE; MICROLARYNGOSCOPY; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL; PLASMA CELL GRANULOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPEECH THERAPY; TUMOR VOLUME; VIRUS STRAIN;

EID: 78649461902     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21232     Document Type: Article

References (20)

1. Coffin CM, Watterson J, Priest JR, Dehner LP,. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995; 19: 859-872.
2. Wenig BM, Devaney K, Bisceglia M,. Inflammatory myofibroblastic tumor of the larynx. A clinicopathologic study of eight cases simulating a malignant spindle cell neoplasm. Cancer 1995; 76: 2217-2229.
3. Suh SI, Seol HY, Lee JH, et al. Inflammatory myofibroblastic tumor of the larynx. Head Neck 2006; 28: 369-372.
4. Rodrigues M, Taylor RJ, Sun CC, Wolf JS,. Inflammatory myofibroblastic tumor of the larynx in a 2-year-old male. ORL J Otorhinolaryngol Relat Spec 2005; 67: 101-105.
5. Alaani A, Hogg R, Warfield AT, Olliff J, Jennings C,. Air bag injury as a cause of inflammatory myofibroblastic pseudotumour of the subglottic larynx progressing to myositis ossificans. Acta Otolaryngol 2005; 125: 674-677.
6. Su W, Ko A, O'Connell T, Applebaum H,. Treatment of pseudotumors with nonsteroidal antiinflammatory drugs. J Pediatr Surg 2000; 35: 1635-1637.
7. Lichter P, Bentz M, Joos S,. Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and comparative genomic hybridization. Methods Enzymol 1995; 254: 334-359.
8. Volker HU, Scheich M, Holler S, et al. Differential diagnosis of laryngeal spindle cell carcinoma and inflammatory myofibroblastic tumor-report of two cases with similar morphology. Diagn Pathol 2007; 2: 1.
9. Ma Z, Hill DA, Collins MH, et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003; 37: 98-105.
10. Su LD, Atayde-Perez A, Sheldon S, Fletcher JA, Weiss SW,. Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod Pathol 1998; 11: 364-368.
11. Griffin CA, Hawkins AL, Dvorak C, Henkle C, Ellingham T, Perlman EJ,. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res 1999; 59: 2776-2780.
12. Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA,. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol 2001; 14: 569-576.
13. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000; 157: 377-384.
14. Gleason BC, Hornick JL,. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 2008; 61: 428-437.
15. Brooks JK, Nikitakis NG, Frankel BF, Papadimitriou JC, Sauk JJ,. Oral inflammatory myofibroblastic tumor demonstrating ALK, p53, MDM2, CDK4, pRb, and Ki-67 immunoreactivity in an elderly patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 716-726.
16. Oka K, Tomonaga Y, Nakazawa T, et al. Malignant transformation of human diploid fibroblasts and suppression of their anchorage independence by introduction of chromosome 13. Genes Chromosomes Cancer 1999; 26: 47-53.
17. Neild GH, Rodriguez-Justo M, Wall C, Connolly JO,. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 2006; 4: 23.
18. Mizukami H, Yajima N, Wada R, et al. Pancreatic malignant fibrous histiocytoma, inflammatory myofibroblastic tumor, and inflammatory pseudotumor related to autoimmune pancreatitis: characterization and differential diagnosis. Virchows Arch 2006; 448: 552-560.
19. Sirvent N, Hawkins AL, Moeglin D, et al. ALK probe rearrangement in a t(2;11:2)(p23;p15;q31) translocation found in a prenatal myofibroblastic fibrous lesion: toward a molecular definition of an inflammatory myofibroblastic tumor family? Genes Chromosomes Cancer 2001; 31: 85-90.
20. Bellezza G, Cavaliere A, Del Sordo R, Sidoni A,. Inflammatory myofibroblastic tumor of the larynx with anaplastic lymphoma kinase (ALK) protein overexpression. A case report. Tumori 2006; 92: 449-451.